Budi Starch Sweetener Tbk vs Cipta Sarana Medika Tbk. — how do they compare? Budi Starch Sweetener Tbk trades at Rp206 (market cap 926.79B, 32K 24h volume), while Cipta Sarana Medika Tbk. trades at Rp64 (market cap 160.67B, 23.38M 24h volume). The key difference: Budi Starch Sweetener Tbk is far larger — about 5.8× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (23.38M versus 32K). Which is the better fit depends on your goals.
| BUDI | DKHH | |
|---|---|---|
Market Cap | 926.79B | 160.67B |
Volume | 32K | 23.38M |
Lot | 320 | 233.77K |
Turnover | 6.59M | 1.52B |
Average Price | 206 | 65.04 |
Value | 6.59M | 1.52B |
Indicative Equilibrium Price | — | 64 |
Indicative Equilibrium Volume | — | 1.35K |
Trailing returns across standard periods
Latest headlines on both assets
PT Budi Starch & Sweetener Tbk (the Company) formerly Budi Acid Jaya (BAJ) was established based on Notarial Deed No. 15 dated January 15, 1979 of Henk Limanow, SH., public notary in Jakarta. PT Budi Starch & Sweetener Tbk is the world`s largest tapioca starch producer. BAJ is an integrated cassava based manufacturer : citric acid, modified tapioca starch and monosodium glutamate (MSG). It also produces sulphuric acid and poly propelene woven bag.
Read more on BUDI →PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →